Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-014757
Filing Date
2025-02-18
Accepted
2025-02-18 16:07:24
Documents
1
Period of Report
2025-02-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm256830-8_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm256830-8_4seq1.xml 4 3989
  Complete submission text file 0001104659-25-014757.txt   5653
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O REXAHN PHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD SUITE 455 ROCKVILLE MD 20850
Business Address
Swirsky Douglas J (Reporting) CIK: 0001375884 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36598 | Film No.: 25634885